Author

H. Akiba

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

C. Okumura· 1 shared H. Kamada· 1 shared H. Nakano· 1 shared H. Ohno· 1 shared H. Yagita· 1 shared J. Fujita· 1 shared K. Entzminger· 1 shared K. Moriwaki· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Okumura

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A high-sensitivity ELISA for detection of human FGF18 in culture supernatants from tumor cell lines

Y. Tsuchiya, S. Komazawa-Sakon, M. Tanaka, T. Kanakogi, K. Moriwaki, H. Akiba, H. Yagita, K. Okumura, K. Entzminger, C. Okumura, T. Maruyama, H. Nakano

This paper develops a high-sensitivity ELISA for detecting human FGF18 in tumor cell culture supernatants and validates its use in detecting murine FGF18 in mouse sera.

bioRxiv · Jun 16, 2023Cancer Biology

Development of a 1:1-binding biparatopic anti-TNFR2 antagonist by epitope selection

H. Akiba, J. Fujita, T. Ise, K. Nishiyama, T. Miyata, T. Kato, K. Namba, H. Ohno, H. Kamada, S. Nagata, K. Tsumoto

This study develops a biparatopic anti-TNFR2 antagonist that binds in a 1:1 ratio, preventing unwanted signal transduction and suppressing regulatory T cell proliferation.

bioRxiv · Dec 15, 2022Biochemistry